# Combined Therapy for Hepatocellular Carcinoma >3-<5 cm

> **NCT04721470** · NA · COMPLETED · sponsor: **Zagazig University** · enrollment: 278 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** Combined therapy
- **PROCEDURE:** Microwave ablation
- **PROCEDURE:** Transarterial chemoembolization

## Key facts

- **NCT ID:** NCT04721470
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2020-05-15
- **Final completion:** 2020-10-20
- **Target enrollment:** 278 (ACTUAL)
- **Last updated:** 2021-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04721470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04721470, "Combined Therapy for Hepatocellular Carcinoma >3-<5 cm". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04721470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*